Alps Group Inc
corporate_fare Company Profile
Alps Group Inc (NASDAQ:ALPS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 13 items for ALPS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-07, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for ALPS spans 6-K, 424B3, F-1.
Recent high-impact activity:
- Alps Group Posts 44% Revenue Growth to $4.9M and a Narrower Loss in Fiscal 2026
- Alps Group Revenue Jumps 44% to $4.9M, Net Loss Narrows in Fiscal 2026
- Alps Group Launches Patient-Derived Organoid Program for Personalized Cancer Care
- Alps Group Launches Organoid Program, Aims for Malaysia's First Clinically Validated Platform
- Alps Group Subsidiary MyGenome Achieves Key Whole Genome Sequencing Accreditation
Financial Snapshot
Insider Transactions
ALPS files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.